1 g major molecular response, were tested at a
significance level of 0.0001 to adjust for multiple comp
2 was protocol-specified and used a two-sided
significance level of 0.001 and a p value at or below th
3 ed with relapse-free survival at a stringent
significance level of 0.001 to account for multiple comp
4 ignificantly associated (Bonferroni-adjusted
significance level of 0.003) with many ion properties re
5 ention type and occasion factor time, with a
significance level of 0.01.
6 fied one-sided stratified log rank test at a
significance level of 0.02.
7 error rate of 0.05 to calculate an adjusted
significance level of 0.0253.
8 near and generalized linear mixed model at a
significance level of 0.05 (P value).
9 on and maintenance was tested at a two-sided
significance level of 0.05 by a stratified Cox regressio
10 ore nearly impossible to ensure a genomewide
significance level of 0.05 using the available statistic
11 animals required to obtain 80% power with a
significance level of 0.05 varied substantially across b
12 A
significance level of 0.05 was applied for 95% confidenc
13 Adopting a cFDR nominal
significance level of 0.05, 287 loci were identified for
14 llowed to discriminate 4 more regions with a
significance level of 0.05.
15 of zero between-group difference tested at a
significance level of 0.05.
16 On the basis of an interim analysis
significance level of 0.081 (overall one-sided significa
17 roportional hazards regression models with a
significance level of 0.1 were used to build up univaria
18 vidual servers based on TM-score at a t-test
significance level of 0.1%.
19 ent differences were assessed with a 2-sided
significance level of 0.10.
20 gnificance level of 0.081 (overall one-sided
significance level of 0.20, power of 0.80, and O'Brien-F
21 power of 80% with concordant sib pairs at a
significance level of .
0001 are given, stratified by par
22 rly all were much smaller than the customary
significance level of.
0001 for genomewide scans.
23 A Bonferroni-corrected
significance level of .
001/6 = .00017 was used to accomm
24 the sample sizes required for 80% power at a
significance level of.
001 and also used simulation metho
25 d-sample t tests with a Bonferroni-corrected
significance level of .
005 were employed alongside mean
26 group comparisons used a Bonferroni-adjusted
significance level of .
017.
27 ific performance levels by using a two-sided
significance level of .
0294.
28 A 2-tailed t test with a
significance level of .
05 was used for all comparisons.
29 using a Benjamini-Hochberg correction with a
significance level of .
05.
30 ilcoxon signed-rank significance test with a
significance level of .
05.
31 45 with approximately 85% power at two-sided
significance level of .
05.
32 t were used for statistical analyses, with a
significance level of .
05.
33 nalyses were done by using chi(2) tests with
significance level of .
05.
34 ession analysis and two-sided t tests with a
significance level of .
05.
35 rd ratio (HR) of 0.75, a power of 80%, and a
significance level of 10%.
36 rcentage of activated voxels at single-voxel
significance levels of 10(-2), 10(-3), and 10(-4) within
37 ided P = .055; two-sided P = .11 [predefined
significance level of .
10, one-sided]).
38 emissions above 200 megaelectron volts at a
significance level of 17sigma from the globular cluster
39 14 of 443 experimentally determined sites (a
significance level of 18 standard deviations).
40 tein or DNA sequences in the database at the
significance level of 1e-6.
41 tal arms) with 81% power while maintaining a
significance level of 2.5% in a two-sided test for each
42 ect a 33% prolongation of PFS at a one-sided
significance level of .
2.
43 th higher liver fat levels at the exome-wide
significance level of 3.6 x 10(-7): two in PNPLA3, an es
44 que genetic regions at a Bonferroni-adjusted
significance level of 3.8x10(-11).
45 ociated with schizophrenia at the suggestive
significance level of 5 x 10(-5).
46 Nine loci reached the genome-wide
significance level of 5 x 10(-8) including six already k
47 extracted fifty SNPs associated with UNa at
significance level of 5 x 10(-8), but further removed th
48 circulating phylloquinone at the genome-wide
significance level of 5 x 10(-8).
49 ect a putative mutant allele at a genomewide
significance level of 5% can usually be achieved in prac
50 A
significance level of 5% was applied to demonstrate the
51 A
significance level of 5% was used.
52 efficacy end point at week 16 at the 2-sided
significance level of 5%, the observed trends in anatomi
53 d linear regression model were applied and a
significance level of 5%.
54 analysis of variance and chi(2) tests with a
significance level of 5%.
55 orphometry were statistically processed at a
significance level of 5%.
56 to final report was determined at a nominal
significance level of 5%.
57 o SPSS software version 22 and analyzed at a
significance level of 5%.
58 re meta-analyzed, and a Bonferroni-corrected
significance level of 7.7 x 10(-4) was used to account f
59 tistical analyses were conducted following a
significance level of 95% (P < 0.05).
60 ivariate regression analysis were applied at
significance level of 95% (P </= 0.05) to compare study
61 tion models were created and verified with a
significance level of 95%.
62 vents and number of positions as well as the
significance level of a given data set.
63 9p23, and 16q24.1, exceeding the statistical
significance level of a LOD score >2.0.
64 We recover 75%-85% (depending on
significance level) of all regulatory sites from a stand
65 4 specificity was evaluated at the one-sided
significance level of alpha = .025 with a -10% margin.
66 by comparing the 90% CI (corresponding to a
significance level of alpha = .05) with the predefined n
67 ecificity were evaluated using the two-sided
significance level of alpha = .05.
68 Analyses included a
significance level of alpha = .10 with no adjustments fo
69 clitaxel weekly resulted in a significantly (
significance level of alpha = .10) higher pCR rate of 44
70 and partial remission, tested at a one-sided
significance level of alpha = .10.
71 0.73) using one-sided binomial tests with a
significance level of alpha=0.025.
72 dological and statistical advances to assess
significance levels of changes in individual patients, a
73 Results of the QTL analyses indicated that
significance levels of detected QTL were greatly improve
74 The
significance level of enrichment is assessed by the perm
75 On this basis and on the basis of pathologic
significance, levels of IL-13, periostin and ECP were fu
76 independent variables, those that reached a
significance level of less than .05 in univariate analys
77 A Bonferroni-corrected
significance level of less than 0.0016 was considered st
78 A
significance level of &
lt; 0.05 was considered in this stud
79 Data were analyzed by SPSS 27 at
significance level of &
lt; 0.05, using independent sample t
80 BMI; weight (kg)/height (m)(2)) at a minimum
significance level of &
lt;/=5 x 10(-7) in the US National H
81 le comparisons with the Bonferroni-corrected
significance level of &
lt;0.0015.
82 nd the t test were used, with a conservative
significance level of P < .001.
83 To adjust for multiple comparisons, a
significance level of P < .01 was chosen.
84 en 2010 and 2019 using the chi(2) test and a
significance level of P < .05.
85 0.075 for liver enzyme concentrations, at a
significance level of P < .05.
86 ssociated with 1-year overall mortality at a
significance level of P < .10 constructed a multivariate
87 power calculation used a 1-sided test with a
significance level of P < .10.
88 er to detect 50% prolongation at a one-sided
significance level of P < .20.
89 ficant positive correlation was found at the
significance level of p < 0.0001 between: the height, le
90 cohort and both the NC and ACA cohorts at a
significance level of P < 0.01.
91 atients and controls were generated, using a
significance level of P < 0.05 in a general linear model
92 292 genes per wood trait using a statistical
significance level of P < 0.05 to maximize discovery.
93 ical analysis was performed in Python with a
significance level of p < 0.05, and results were compare
94 At a
significance level of P < 0.05, CGM Cho, CGM and NAWM tN
95 employed to identify associated factors at a
significance level of p < 0.05.
96 henotype associations with an experimentwise
significance level of P < 0.05.
97 (SNPs) that were associated with NAFLD at a
significance level of P < 10(-5) was examined in adults
98 12 new susceptibility loci (at a genome-wide
significance level of P < 5 x 10(-)(8)) and replicated a
99 ted to prostate cancer risk at a genome-wide
significance level of P < 5 x 10(-8) with the most signi
100 Imposing a Bonferroni-corrected
significance level of P < 5.69 x 10(-6), we identified 3
101 AL PARAMETRIC MAPPING software package and a
significance level of P < or = 0.001, uncorrected for mu
102 oints, but they did not reach a prespecified
significance level of P < or = 25.
103 ) were used for analyses, all at a threshold
significance level of P <.05.75 members responded, inclu
104 associated with angioedema at the genomewide
significance level of P <5 x 10(-8).
105 18p11, and 20q13), with a nominal multipoint
significance level of P< or =.01 or LOD > or =1.18.
106 7 (D17S1301), with evidence for linkage at a
significance level of P<.005.
107 ies using study data confirmed a genome-wide
significance level of P<0.05 (95% CI 0.005-0.0466).
108 We used a statistical
significance level of p<0.05 for a between-group differe
109 Using the
significance level of p<0.05, we found that 59 miRNAs we
110 versus FFS using the 2-sample z-test with a
significance level of P<0.05.
111 fied for 64 nsSNPs, generating a genome-wide
significance level of P=0.002.
112 lateral case, corresponding to a genome-wide
significance level of P=0.034.
113 follow-up 22.8 months); the protocol-defined
significance level of p=0.0419 was not reached.
114 ualised relapse rate after 24 months, with a
significance level of p=0.10.
115 4 studies revealed 66 loci with genome-wide
significance levels of p < 5 x 10(-8).
116 s observed at three Y haplotype clades, with
significance levels of P = 0.002, P = 0.020, and P = 0.0
117 core-based method for estimating genome-wide
significance level of putative QTL effects suitable for
118 LOD score 3.6 is.00191, giving a genomewide
significance level of slightly <.05.
119 CONCLUSIONS/
SIGNIFICANCE: Levels of specific serum phospholipids dif
120 hen based on D', and 11 cM when based on the
significance level of the allelic association.
121 ce determination is applied to represent the
significance level of the genes in a Bayesian inference
122 The
significance level of the test was considered to be P <
123 The statistical
significance levels of the correlations and the pattern
124 oducible determinations of the probabilistic
significance levels of the deviations between theoretica
125 ns were identified for MI at the genome wide
significance level, of which effect sizes at six loci we